CompuGroup Medical SE & Co. KGaA reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was EUR 319.68 million compared to EUR 338.73 million a year ago. Net loss was EUR 15.9 million compared to net income of EUR 13.8 million a year ago. Basic loss per share from continuing operations was EUR 0.3 compared to basic earnings per share from continuing operations of EUR 0.26 a year ago. Diluted loss per share from continuing operations was EUR 0.3 compared to diluted earnings per share from continuing operations of EUR 0.26 a year ago.

For the full year, the company reported sales was EUR 1,227.8 million compared to EUR 1,174.56 million a year ago. Net income was EUR 45.92 million compared to EUR 73.41 million a year ago. Basic earnings per share from continuing operations was EUR 0.88 compared to EUR 1.41 a year ago. Diluted earnings per share from continuing operations was EUR 0.88 compared to EUR 1.4 a year ago.